Bio-Technology General
About
BTG invests heavily in the process of creating new medicines through its research and development centers and through research collaboration with scientific institutes and biotechnology and pharmaceutical companies throughout the world.
Sector Focus
Life Sciences
Series Focus
Series B
Cheque Size
$15.8M - $15.8M
Score Breakdown
23Deal Activity
15Track Record
10Visibility
0Profile
70Community
0Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What type of investor is Bio-Technology General?
BTG invests heavily in the process of creating new medicines through its research and development centers and through research collaboration with scientific institutes and biotechnology and pharmaceutical companies throughout the world.
What kind of firm is Bio-Technology General?
Bio-Technology General is a Company.
Where is Bio-Technology General based?
Bio-Technology General is based in Israel.
What sectors does Bio-Technology General focus on?
Bio-Technology General focuses on Life Sciences.
Similar Investors